The Science of Cancer Survivorship Tuesday, June 28, 2022, 1 p.m. ET This virtual forum will explore research advancing the field of cancer survivorship, identify gaps in knowledge, and explore the future direction of cancer survivorship research.
Register TodayCancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreLong-standing inequities in multiple social determinants of health contribute to significant disparities in the burden of preventable cancer risk factors.
Learn MoreAn estimated 41,260 adults in the United States are expected to be diagnosed with liver cancer. Read about the prevention, screening, and treatment of this type of cancer.
Learn MoreAn early collaboration between AACR Fellows Joseph F. Fraumeni, MD, and Frederick P. Li, MD, defined one of the first cancer predisposition syndromes linked to the most commonly mutated gene across all cancer types.
Read AACR StoriesThe Summer 2022 issue of Cancer Today magazine, with articles on coping scanxiety, marking cancer milestones, dealing with the pain of grief, and more is now available.
Cancer TodayWhether honoring a special person or a special day, a donation to the American Association for Cancer Research (AACR) has a lasting impact.
Donate NowAACR grants support researchers domestically and abroad at every career stage, representing a global commitment to cancer prevention, early detection, interception, and cure.
The report provides a comprehensive overview of the latest research on cancer disparities and calls for policies to reduce disparities and achieve cancer health equity.
Learn MoreThe AACR and its more than 50,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreFor the woman with Lynch syndrome, a delayed colonoscopy highlighted the impact of the pandemic on cancer screening.
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn Morenew therapeutics against cancer were approved by the FDA from August 1, 2020, to July 31, 2021
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2018
Learn More